US Healthcare Advertising Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021



Health related issues are growing rapidly all over the world making healthcare a major issue of concern. Health problems are fuelled by poverty, aging population and obesity in both developed and developing societies. As the economies grow and global disposable incomes rise, individuals demand better care and advanced medical interventions. Thus, the pace of growth in global health care spending, particularly in developing nations, is expected to accelerate rapidly for the foreseeable future. The healthcare spending in the United States is far greater than other countries. Currently, the United States has one of the highest per capita expenditure on healthcare with estimates suggesting that by 2020 the US will spend approximately 28% of its GDP on healthcare.

                                                        US Healthcare Advertising Market

The increasing value that people place on social media and advertisements has brought about the integration of marketing and healthcare in the recent past. Healthcare corporations are increasing their expenditure on advertising through various channels like, television, print ads, social media, detailing, etc. and there is a shift of healthcare brands putting more money into the digital space.

The key healthcare segments analysed in this report are the Pharmaceutical (small molecule drugs) Market, Biopharmaceutical Market, Vaccines Market and Over-the-Counter (OTC) Drugs Market in the United States. For each of the healthcare segments, the report provides the share of various advertising channels such as detailing, sampling, Direct-to-Consumer (DTC), mailing/e-mailing, print advertising, etc.  The report finds that detailing represents the most preferred mode of promotion across all the healthcare segments.

                                            US healthcare advertising market report                                                

The healthcare market in the United States comprises of major players like Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche, among many others. All these pharmaceutical corporations spend a large amount of their earnings on promotions and advertising of their drugs and healthcare products.

IMARC’s new report “US Healthcare Advertising: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021” provides an analytical and statistical insight into the advertising trends in the healthcare sector in the United States. The market analysis includes market trends, key players in the healthcare sector, sales and advertising trends in the different sectors, breakup by advertising channels, etc. The study, which is based both on desk research and multiple waves of qualitative primary research, is a must-read for entrepreneurs, investors, researchers, consultants, business strategists and all those who are planning to foray into US healthcare advertising market in any manner.

 

Key Questions Answered in this Report:

  • How is healthcare advertising different from conventional advertising?
  • What are the different channels for healthcare advertising?
  • What drives the healthcare advertising market in the US?
  • What is the value chain of the healthcare advertising market in the US?
  • What are the current trends in the US healthcare advertising industry?
  • What are the historical, current and future trends of the advertising spend on healthcare sector in the US?
  • What are the historical, current and future sales value trends and advertising spend of the pharmaceutical (small molecule drugs) market in the healthcare sector in the US?
  • What are the historical, current and future sales value trends and advertising spend of the biopharmaceutical market in the US?
  • What are the historical, current and future sales value trends and advertising spend of the vaccines market in the US?
  • What are the historical, current and future sales value trends and advertising spend of the Over-the-Counter (OTC) drugs market in the US?
  • What is the breakup of the key advertising channels of the pharmaceutical market in the US?
  • What is the breakup of the key advertising channels of the biopharmaceutical market in the US?
  • What is the breakup of the key advertising channels of the vaccines market in the US?
  • What is the breakup of the key advertising channels of the Over-the-Counter (OTC) drugs market in the US?
  • Who are the key players in the pharmaceutical market, biopharmaceutical market, vaccines market and Over-the-Counter (OTC) drugs market in the US and what is their advertising spend?
  • Who are the key players in the US healthcare advertising market and what are the trends of their sales and advertising spend?
  • What are the challenges of the healthcare advertising market in the US?

1 Research Methodology and Market Definitions
2 Executive Summary
3 An Overview of Healthcare Advertising in the United States
4 What Drives the Healthcare Advertising Market in the United States?

    4.1 Digitalization and other Technological Advancements
    4.2 Increasing Presence of Generic and Me-too Drugs
    4.3 Government Regulations Supporting DTC Advertising
    4.4 Launch of New Drugs
    4.5 Increased Consumer Reach through Mobile Advertising
    4.6 Other Key Drivers
5 Healthcare Advertising Market: Value Chain
    5.1 DTC Advertising
    5.2 Detailing
6 Current Trends in Healthcare Advertising
    6.1 Focus on Content
    6.2 Rise of Multichannel Marketing
    6.3 Targeting Consumers with Local Advertising
    6.4 Reliance on Social Media
    6.5 Surging Mobile Marketing
    6.6 Consumers Becoming Researchers
    6.7 Information Dispensed through Videos
    6.8 Increasing Importance of Online Reviews
7   US Healthcare Advertising Market: SWOT Analysis
    7.1 Strength
    7.2 Weakness
    7.3 Opportunities
    7.4 Threats
8   US Healthcare Advertising market: Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Bargaining Power of Buyers
    8.3    Bargaining Power of Suppliers
    8.4    Degree of Competition
    8.5    Threat of New Entrants
    8.6    Threat of Substitutes
9 US Healthcare Advertising Market
    9.1 Historical and Current Market Trends
    9.2 Market Segmentation by Product Type
        9.2.1 Pharmaceutical (Small Molecule Drugs) Advertising Market
            9.2.1.1 Historical, Current and Future Trends in the Pharmaceutical (Small Molecule Drugs) Market  
            9.2.1.2 Historical, Current and Future Trends in the Pharmaceutical (Small Molecule) Advertising Market
            9.2.1.3 Market Breakup by Advertising Channel
            9.2.1.4 Advertising Spend by Key Players
        9.2.2 Biopharmaceutical Market
            9.2.2.1 Historical, Current and Future Market Trends in the Biopharmaceutical Market        
            9.2.2.2 Historical, Current and Future Market Trends in the Biopharmaceutical Advertising Market
            9.2.2.3 Market Breakup by Advertising Channel
            9.2.2.4 Advertising spend by Key Players
        9.2.3 Vaccines Market
            9.2.3.1 Historical, Current and Future Market Trends in the Vaccines Market
            9.2.3.2 Historical, Current and Future Market Trends in the Vaccines Advertising Market
            9.2.3.3 Market Breakup by Advertising Channel
            9.2.3.4 Advertising Spend by Key Players
        9.2.4 Over-the-Counter Drugs Market
            9.2.4.1 Historical, Current and Future Market Trends in the OTC Drugs Market
            9.2.4.2 Historical, Current and Future Market Trends in the OTC Drugs Advertising Market
            9.2.4.3 Market Breakup by Channel
            9.2.4.4 Advertising Spend by Key Players
10 Major Players: Sales and Advertising Spend
    10.1 Advertising Spend by Major Pharma Companies
        10.1.1 Johnson & Johnson
            10.1.1.1 US Sales
            10.1.1.2 Advertising Spend by Channel
            10.1.1.3 Global Sales and Advertising Spend
        10.1.2 Pfizer
            10.1.2.1 US Sales
            10.1.2.2 Advertising Spend by Channel
            10.1.2.3 Global Sales and Advertising Spend
        10.1.3 Merck & Co.
            10.1.3.1 US Sales
            10.1.3.2 Advertising Spend by Channel
            10.1.3.3 Global Sales and Advertising Spend
        10.1.4 GlaxoSmithKline
            10.1.4.1 US Sales
            10.1.4.2 Advertising Spend By Channel
            10.1.4.3 Global Sales and Advertising Spend
        10.1.5 Eli Lilly
            10.1.5.1 US Sales
            10.1.5.2 Advertising Spend by Channel
            10.1.5.3 Global Sales and Advertising Spend
        10.1.6 Novartis
            10.1.6.1 US Sales
            10.1.6.2 Total Sales of Different Segments
            10.1.6.3 Advertising Spend by Channel
            10.1.6.4 Global Sales and Advertising Spend
        10.1.7 Sanofi
            10.1.7.1 US Sales
            10.1.7.2 Advertising Spend on Different Segments
            10.1.7.3 Global Sales and Advertising Spend
        10.1.8 AstraZeneca
            10.1.8.1 US Sales
            10.1.8.2 Advertising Spend by Channel
            10.1.8.3 Global Sales and Advertising Spend
        10.1.9 Roche
            10.1.9.1 US Sales
            10.1.9.2 Advertising Spend on Different Segments
            10.1.9.3 Global Sales and Advertising Spend
        10.1.10 Bayer HealthCare
            10.1.10.1 US Sales
            10.1.10.2 Advertising Spend on Different Segments
            10.1.10.3 Global Sales and Advertising Spend
        10.1.11 Bristol- Myers Squibb
            10.1.11.1 US Sales
            10.1.11.2 Advertising Spend by Channel
            10.1.11.3 Global Sales and Advertising Spend
11 Market Challenges
    11.1 Trust Gap between Consumers and Advertisers
    11.2 Strict Rules and Regulations by FDA
    11.3 Unethical Practices
    11.4 Macroeconomic Scenario
    11.5 Other Challenges
 

List of Figures

Figure 1: US: Breakup of Healthcare Market
Figure 2: US: Healthcare Industry Digital Ad Spending (in USD Billion), 2013-2019
Figure 3: US Healthcare Advertising Market: SWOT Analysis
Figure 4: US Healthcare Advertising Market: Porter’s Five Forces Analysis
Figure 5: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2009-2016
Figure 6: US: Pharmaceuticals (Small Molecule Drugs): Sales Forecast (in USD Billion), 2017-2021
Figure 7: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2009-2016
Figure 8: US: Pharmaceutical (Small Molecule Drugs) Market: Sales Forecast (in USD Billion), 2017-2021
Figure 9: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend (in USD Billion), 2009-2016
Figure 10: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend Forecast (in USD Billion), 2017-2021
Figure 11: US: Pharmaceutical (Small Molecule Drugs) Market Advertising Spend: Breakup by Channels (in USD Billion), 2009-2016
Figure 12: US: Biopharmaceutical Market: Sales (in USD Billion), 2009-2016
Figure 13: US: Biopharmaceutical Market: Sales Forecast (in USD Billion), 2017-2021
Figure 14: US: Biopharmaceutical Market: Advertising Spend (in USD Billion), 2009-2016
Figure 15: US: Biopharmaceutical Market: Advertising Spending Forecast (in US$ Billion), 2015-2020
Figure 16: US: Biopharmaceutical Market: Advertising Spend: Breakup by Channels (in %), 2016
Figure 17: US: Biopharmaceutical Market: Advertising Spend Breakup by Different Providers (in %), 2016
Figure 18: US: Vaccines Market: Sales (in USD Billion), 2009-2016
Figure 19: US: Vaccines Market: Sales Forecast (in USD Billion), 2017-2021
Figure 20: US: Vaccines Market: Advertising Spend (in USD Billion), 2009-2016
Figure 21: US: Vaccines Market: Advertising Spend (in USD Billion), 2017-2021
Figure 22: US: OTC Drugs Market: Sales (in USD Billion), 2009-2016
Figure 23: US: OTC Drugs Market: Sales Forecast (in USD Billion), 2017-2021
Figure 24: US: OTC Drugs Market: Advertising Spend (in USD Billion), 2009-2016
Figure 25: US: OTC Drugs Market: Advertising Spend Forecast (in USD Billion), 2017-2021
Figure 26: US: OTC Drugs Market: Advertising Spend: Breakup by Channels (in %), 2016
Figure 27: US: Advertising Spend by Top Companies Breakup (in %), 2016
Figure 28: US: Pharmaceutical Marketing: Expenditure Breakup by Type (in %), 2016
Figure 29: Johnson & Johnson: US and Rest of the World Sales (in USD Billion), 2013-2015
Figure 30: Johnson & Johnson: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 31: Johnson & Johnson: Global Sales and Advertising Spend (in USD Billion), 2013-2015
Figure 32: Pfizer: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 33: Pfizer: Advertising Spend: Breakup by Different Channels in USA (in %), 2012
Figure 34: Pfizer: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 35: Merck & Co: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 36: Merck & Co: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 37: Merck & Co: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 38: GSK: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 39: GSK: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 40: GSK: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 41: Eli Lilly: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 42: Eli Lilly: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 43: Eli Lilly: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 44: Novartis: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 45: Novartis: Advertising Spend on Different Channels (in %), 2014
Figure 46: Novartis: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 47: Sanofi: US and Rest of the World sales (in USD Million), 2013-2015
Figure 48: Sanofi: Breakup of Spending on Different Products (in %), 2015
Figure 49: Sanofi: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 50: AstraZeneca: US and Rest of the World sales (in USD Million), 2013-2015
Figure 51: AstraZeneca: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 52: AstraZeneca: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 53: Roche: US and Rest of the World sales (in USD Million), 2013-2015
Figure 54: Roche: Breakup of Spending on Different Divisions (in %), 2014
Figure 55: Roche: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 56: Bayer Healthcare: US and Rest of the World sales (in USD Million), 2013-2015
Figure 57: Bayer & Healthcare: Breakup of Spending on Different Channels (in %), 2015
Figure 58: Bayer Healthcare: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 59: Bristol-Myers Squibb: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 60: Bristol-Myers Squibb: Breakup of Spending on Different Channels (in %), 2014
Figure 61: Bristol-Myers Squibb: Global Sales and Advertising Spend (in USD Million), 2013-2015
 

List of Tables

Table 1: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend by Key Players, 2015
Table 2: US: Biopharmaceutical Market: Advertising Spend by Key Players, 2015
Table 3: US: Vaccines Market: Advertising Spend by Key Players, 2015
Table 4: US: OTC Drugs Market: Advertising Spend by Key Players, 2015
Table 5: US: Advertising Spend by Major Players, (in USD Million), 2015
Table 6: Pfizer: Advertising Spend on Different Channels (in USD Million), 2012
Table 7: Merck & Co: Advertising Spend on Different Channels (in USD Million), 2015
Table 8: GSK: Advertising Spend on Different Channels (in USD Million), 2012
Table 9: Eli Lilly: Advertising Spend on Different Channels (in USD Million), 2012
Table 10: Novartis: Total Sales of Different Segments (in USD Million), 2013-2015
Table 11: Sanofi: Advertising Spend on Different Products (in USD Million), 2015
Table 12: AstraZeneca: Advertising Spend on Different Channels in the US (in USD Million), 2012
Table 13: Roche: Total Spending on Different Divisions (in USD Million), 2014


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

UAE LED Lights Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

IMARC Group’s latest report titled, “UAE LED Lights Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the market reached a value of SAR 400 Million in 2016, growing at a CAGR of more than 18% during 2009-2016.


Africa E-Learning Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled, “Africa E-Learning Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the Africa e-learning market reached a value of more than US$ 600 Million in 2016, exhibiting a CAGR of around 15% during 2009-2016.


Saudi Arabia LED Lights Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled, “Saudi Arabia LED Lights Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the market reached a value of SAR 469 Million in 2016, growing at a CAGR of around 19% during 2009-2016.


Robotics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Robots are machines which can be programmed to perform certain routine tasks on command. They are faster, more precise and consistent than human beings and thereby offer increased efficiency and productivity. Earlier, robots were primarily used in assembly lines of the automotive industry but their ...


Global Radio Advertising Market Report & Forecast 2017-2022

According to the report by IMARC Group, titled “Global Radio Advertising Market Report & Forecast 2017-2022”, the revenues of the global radio advertising market experienced a steep decline in 2008 and 2009 due to the global financial crisis. From 2010 onwards, however, revenues have continuousl...